• Most Popular
  • Most Shared

Abbott says its cholesterol combo drug proves safe

Mon Mar 31, 2008 11:00am EDT

Stocks

   

CHICAGO, March 31 (Reuters) - Abbott Laboratories Inc. (ABT.N) said its new treatment aimed at cutting triglycerides and raising "good" HDL cholesterol proved safe and effective when taken alone or in combination with other cholesterol-lowering drugs in two studies.

Stocks  |  Global Markets

Abbott's experimental drug, dubbed ABT-335, is the successor to the company's blockbuster TriCor medicine to control triglycerides, a type of blood fat which contributes to clogging of the arteries.

Abbott tested ABT-335 in combination with individual members of the popular statin family of cholesterol drugs, including Merck's (MRK.N) Zocor, generically known as simvastatin, Pfizer's (PFE.N) Lipitor, or atorvastatin, and Astrazeneca's (AZN.L) Crestor, or rosuvastatin.

Abbott presented data at the American College of Cardiology meeting in Chicago from one study testing its drug with Zocor and the other with Lipitor. (Reporting by Debra Sherman, editing by Dave Zimmerman)



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article